Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

DÜSSELDORF, Germany, August 1 /PRNewswire/ --

- Further Focus on Pharma & Life Science

Gerresheimer AG is to discontinue its business in technical plastic systems. The business segment, which primarily manufactures system components for suppliers to the automobile industry, is not part of the core business of pharma & life science. For this purpose the sale process has been started through an international invitation for bids.

"Through the sale of the technical plastics business we are, as previously announced, continuing our focus on the core business of pharma & life science, "says Dr. Axel Herberg, CEO of Gerresheimer AG.

GENEVA and PARIS, August 1 /PRNewswire/ --

SunGard and GL TRADE today announced SunGard's intention to acquire a majority stake in GL TRADE, a global financial software solutions company serving more than 1,600 customers.

COPENHAGEN, July 31 /PRNewswire/ --

- Summary: Phase III Pivotal Study of Ofatumumab in Refractory CLL Meets Primary Endpoint

Genmab A/S (OMX: GEN) and GlaxoSmithKline (LSE and NYSE: GSK) announced today positive top-line results from an interim analysis of the Phase III pivotal study evaluating ofatumumab (HuMax-CD20(R)) to treat two groups of chronic lymphocytic leukemia (CLL) patients with high unmet medical need. At the interim analysis, the study met the primary endpoint in both populations and the results from the secondary endpoints also support the primary endpoint.

MUMBAI, India, July 31 /PRNewswire/ --

- PAT (Standalone) Expands 179% to Rs. 1,699 Million

- The Board Declared Interim Dividend of 200%

Financial Technologies (India) Limited today announced its reviewed unaudited financial results for the quarter ended June 30, 2008.

Highlights:

- Total income increased by 146% to Rs. 2,540 million in Q1 2008-09. - PAT increased by 179% to Rs. 1,699 million. - Declared an interim dividend of 200%.

LONDON, July 31 /PRNewswire/ --

- ATTN: North West Editors

Members of Unite, the UK's largest trade union, have agreed to step up action short of a strike and give notice of further strike action.

The decision to strike comes after the hospital trust are continuing to force low paid staff to wait three weeks for their pay by changing the payroll system.

Brian Nelson, Unite Regional Industrial Organiser, said: "We had hoped that the trust would see sense and continue with a weekly payroll. It is particularly frustrating for our members when the trust can continue weekly payment for other NHS staff across the Wirral.

NEW YORK, July 31 /PRNewswire/ --

- Including embedded 4G technologies in mobile devices will change dealings between network operators and device suppliers, says Unstrung Insider

A major push to include embedded 4G technologies in a wide range of mobile and consumer devices will create a built-in market for anticipated 4G services such as mobile WiMax and LTE, but it also will force some fundamental changes in the mobile industry ecosystem, particularly in the relationships between network operators and device suppliers, according to the latest report from Unstrung Insider (www.unstrung.com/insider), a paid research service from TechWeb's Unstrung (www.unstrung.com) and Light Reading (www.lightreading.com).